These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34155149)

  • 21. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.
    Kim N; Yun M; Oh YJ; Choi HJ
    J Microbiol; 2018 Mar; 56(3):172-182. PubMed ID: 29492874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gut microbiota and central nervous system development.
    Principi N; Esposito S
    J Infect; 2016 Dec; 73(6):536-546. PubMed ID: 27725185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of Gut Microbial Diversity through Non-Pharmaceutical Approaches to Treat Schizophrenia.
    Munawar N; Ahmad A; Anwar MA; Muhammad K
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan.
    Snigdha S; Ha K; Tsai P; Dinan TG; Bartos JD; Shahid M
    Pharmacol Ther; 2022 Mar; 231():107978. PubMed ID: 34492236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects and Mechanisms of Probiotics, Prebiotics, Synbiotics, and Postbiotics on Metabolic Diseases Targeting Gut Microbiota: A Narrative Review.
    Li HY; Zhou DD; Gan RY; Huang SY; Zhao CN; Shang A; Xu XY; Li HB
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy.
    Hsu CN; Hou CY; Hsu WH; Tain YL
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbiomes in physiology: insights into 21st-century global medical challenges.
    Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
    Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Crosstalk between the Gut Microbiota Composition and the Clinical Course of Allergic Rhinitis: The Use of Probiotics, Prebiotics and Bacterial Lysates in the Treatment of Allergic Rhinitis.
    Kaczynska A; Klosinska M; Chmiel P; Janeczek K; Emeryk A
    Nutrients; 2022 Oct; 14(20):. PubMed ID: 36297012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiota on biotics: probiotics, prebiotics, and synbiotics to optimize growth and metabolism.
    Edwards PT; Kashyap PC; Preidis GA
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G382-G390. PubMed ID: 32755308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut Microbiota and Pathophysiology of Depressive Disorder.
    Kunugi H
    Ann Nutr Metab; 2021; 77 Suppl 2():11-20. PubMed ID: 34350881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the gut microbiota to treat alcoholic liver diseases: evidence and promises.
    Leclercq S; de Timary P; Stärkel P
    Acta Gastroenterol Belg; 2020; 83(4):616-621. PubMed ID: 33321019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia.
    Zeng C; Yang P; Cao T; Gu Y; Li N; Zhang B; Xu P; Liu Y; Luo Z; Cai H
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110097. PubMed ID: 32916223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations of gut microbiota alterations with clinical, metabolic, and immune-inflammatory characteristics of chronic schizophrenia.
    Misiak B; Pawlak E; Rembacz K; Kotas M; Żebrowska-Różańska P; Kujawa D; Łaczmański Ł; Piotrowski P; Bielawski T; Samochowiec J; Samochowiec A; Karpiński P
    J Psychiatr Res; 2024 Mar; 171():152-160. PubMed ID: 38281465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders.
    Socała K; Doboszewska U; Szopa A; Serefko A; Włodarczyk M; Zielińska A; Poleszak E; Fichna J; Wlaź P
    Pharmacol Res; 2021 Oct; 172():105840. PubMed ID: 34450312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Probiotics, prebiotics and colorectal cancer prevention.
    Ambalam P; Raman M; Purama RK; Doble M
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):119-31. PubMed ID: 27048903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering the Gut Microbiome for Treatment of Obesity: A Review of Current Understanding and Progress.
    Lim YY; Lee YS; Ooi DSQ
    Biotechnol J; 2020 Oct; 15(10):e2000013. PubMed ID: 32663372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microbiota-Orientated Treatments for Major Depression and Schizophrenia.
    Fond GB; Lagier JC; Honore S; Lancon C; Korchia T; Sunhary De Verville PL; Llorca PM; Auquier P; Guedj E; Boyer L
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32276499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut-microbiota modulation: The impact of thegut-microbiotaon osteoarthritis.
    Arora V; Singh G; O-Sullivan I; Ma K; Natarajan Anbazhagan A; Votta-Velis EG; Bruce B; Richard R; van Wijnen AJ; Im HJ
    Gene; 2021 Jun; 785():145619. PubMed ID: 33781857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out.
    Conti G; D'Amico F; Fabbrini M; Brigidi P; Barone M; Turroni S
    Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.